Paramesonephric duct

From WikiMD's WELLNESSPEDIA

(Redirected from Müllerian duct)

Paramesonephric duct (also known as the Müllerian duct) is a structure important in the embryonic development of the female reproductive system. The paramesonephric ducts are paired ducts on the lateral sides of the urogenital ridge that give rise to the uterine tubes, uterus, and part of the vagina in females. In males, these ducts regress due to the action of anti-Müllerian hormone (AMH) produced by the Sertoli cells of the testes.

Development[edit]

During embryogenesis, the paramesonephric ducts develop in both male and female embryos, adjacent to the mesonephric ducts. In females, the absence of AMH allows the paramesonephric ducts to differentiate into the fallopian tubes, the uterus, and the upper portion of the vagina. This process begins around the sixth week of gestation and is largely complete by the 22nd week. The lower portion of the vagina is formed from the urogenital sinus.

In males, the presence of AMH causes the regression of the paramesonephric ducts, a process that is usually complete by the 10th week of gestation. The remnants of the paramesonephric ducts in males can sometimes persist as small structures known as the appendix testis and the prostatic utricle.

Clinical Significance[edit]

Abnormalities in the development of the paramesonephric ducts can lead to various congenital conditions. For example, incomplete regression of the ducts in males can result in persistent Müllerian duct syndrome (PMDS), where remnants of the female reproductive tract are found in an otherwise normally developed male. In females, malformations can result in uterine and vaginal anomalies, such as a bicornuate uterus or vaginal atresia, which may impact fertility and require surgical intervention.

Diagnosis and Treatment[edit]

Diagnosis of paramesonephric duct anomalies typically involves imaging techniques such as ultrasound, MRI, or laparoscopy. Treatment depends on the specific condition and its severity but may include surgical correction to restore normal anatomy or improve function.

See Also[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.